GetTopicDetailResponse(id=7f1b25e40ce, topicName=優(yōu)先評審, introduction=優(yōu)先評審, content=null, image=null, comments=2, allHits=1028, url=https://h5.medsci.cn/topic?id=25740, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=59622, tagList=[TagDto(tagId=59622, tagName=優(yōu)先評審)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2081218, encodeId=d9112081218db, content=<a href='/topic/show?id=7f1b25e40ce' target=_blank style='color:#2F92EE;'>#優(yōu)先評審#</a>, objectTitle=PD-1單抗Opdivo聯(lián)合TKI抑制劑Cabometyx治療腎癌，獲得FDA優(yōu)先評審, objectType=article, longId=202354, objectId=f8f120235495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f120235495, replyNumber=0, likeNumber=101, createdTime=2021-05-02, rootId=0, userName=仁心濟世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f120235495, moduleTitle=PD-1單抗Opdivo聯(lián)合TKI抑制劑Cabometyx治療腎癌，獲得FDA優(yōu)先評審, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f8f120235495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081217, encodeId=4ee6208121edd, content=<a href='/topic/show?id=7f1b25e40ce' target=_blank style='color:#2F92EE;'>#優(yōu)先評審#</a>, objectTitle=FDA優(yōu)先評審再生元和賽諾菲特應(yīng)性皮炎藥物dupilumab, objectType=article, longId=78916, objectId=8d8de89167d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d8de89167d, replyNumber=0, likeNumber=101, createdTime=2017-02-09, rootId=0, userName=仁心濟世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d8de89167d, moduleTitle=FDA優(yōu)先評審再生元和賽諾菲特應(yīng)性皮炎藥物dupilumab, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8d8de89167d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
